1-17 of 17 Results

Title Investigator Disease(s)

AZD9833 +/- Palbociclib in Women with ER Positive, HER2 Negative Advanced Breast Cancer

[Protocol 19-1001]
Jason Incorvati
  • Breast
  • Assessing Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

    [Protocol 17-2012]
    Aruna Padmanabhan
  • Breast
  • Doxorubicin+Cyclophosphamide and Paclitaxel with or without Carboplatin for Triple-Neg Breast Cancer

    [Protocol 15-6007]
    Aruna Padmanabhan
  • Breast
  • Fluoroestradiol PET as Predictive Measure for Endocrine-Therapy Patients w Metastatic Breast Cancer

    [Protocol 16-2010]
    Jian Q. (Michael) Yu
  • Breast
  • Informal Caregiver Burden in Later Stage Cancer: Economic and Health Outcomes

    [Protocol 15-6002]
    Laura Siminoff
  • Multiple
  • Mk-3475 Preventative Therapy for Triple Receptor-Negative/Positive Lymph Nodes Breast Cancer

    [Protocol 17-2010]
    Elias Obeid
  • Breast
  • Molecular Analysis for Therapy Choice (MATCH)

    [Protocol 15-7002]
    Lori Goldstein
  • Multiple
  • Nodal XRT in patients who have Pathologically Negative Axilla after Neoadjuvant Chemotherapy

    [Protocol TEMPLERTOG1304]
    Bizhan Micaily
  • Breast
  • ONC201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

    [Protocol 15-1009]
    Anthony Olszanski
  • Multiple
  • Pembrolizumab vs. Placebo + Chemo for High-Risk-Early-Stage ER+/HER2- Breast Cancer

    [Protocol 18-1075]
    Elias Obeid
  • Breast
  • Platinum Based Chemo vs Xeloda to treat Triple-Negative/Basal-Like Breast Cancer post NCAT

    [Protocol 15-2002]
    Jennifer Winn
  • Breast
  • Rebastinib +/- Paclitaxel for advanced or Metastatic Solid Tumors

    [Protocol 18-1048]
    Christina Chu
  • Breast
  • Risk Assessment Program (RAP) Registry

    [Protocol IRB09831]
    Mary Daly
  • Multiple
  • Safety of Keytruda with Paraplatin and Gemzar in Patients with Metastatic Breast Cancer

    [Protocol 16-1013]
    Elias Obeid
  • Breast
  • Tecentriq with Taxol, Herceptin, and Perjeta in treating Metastatic HER-2 Positive Breast Cancer

    [Protocol 17-1010]
    Lori Goldstein
  • Multiple
  • Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

    [Protocol 19-2002]
    Catherine Tuite
  • Breast
  • nab-paclitaxel +\- mifepristone for advanced glucocorticoid receptor + triple-negative breast cancer

    [Protocol 18-1017]
    Elias Obeid
  • Breast